BSENATIONAL PLASTIC TECHNOLOGIES· Industrial ProductsHighNeutral
Announced Fri, 31 Jul, 2026 · 18:52 IST

Q1 FY27 results: revenue up 28.5% YoY; PAT at Rs 256 lakh; auditor, MD reappointed

Revenue Growth 20pctEbitda Margin CompressionResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.8%Reaction day
₹236.00
prior close
₹227.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.3%-0.5% vs market
Plastic Products - Industrial peers, median of 38sector+0.4%+0.4% vs sector

On the reaction day the stock moved 0.5 pts less than Nifty Microcap 250 and 0.4 pts more than its Plastic Products - Industrial peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+5.3
30m
+3.5
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.8+1.3-0.5+0.4+0.4
Next day
+1.7+1.8-0.1+0.3+1.4
2d
-0.8+3.1-3.9+0.0-0.8
3d
+2.7+3.5-0.7+0.0+2.7
4d
-2.0+3.5-5.5-0.1-1.9
5d
-2.2+3.4-5.6-0.4-1.8
1w
-8.5+3.6-12.1-0.2-8.3
15d
-0.3+4.9-5.1+0.0-0.3
1m
-5.5+4.4-9.9+0.1-5.7
2m
+1.7+2.9-1.3-4.3+5.9
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Plastic Products - Industrial peers, median of 38Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q1 FY27 unaudited standalone results. Revenue from operations rose 28.5% YoY to Rs 9518.46 lakh from Rs 7407.25 lakh. Net profit grew 15.3% to Rs 256.45 lakh vs Rs 222.35 lakh. EPS at Rs 4.22 vs Rs 3.66. Total expenses at Rs 9163.75 lakh. Board reappointed C A Patel and Associates as statutory auditor for 5 years (FY27 to FY31) and Arihant Parakh as Managing Director for 3 years from 25 Sep 2026, subject to shareholder approval.

Likely market impact

Strong revenue growth signals demand recovery, though rising costs compressed margins. Reappointments of auditor and MD indicate continuity, pending shareholder approval.